These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 9695216
1. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis]. Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA. Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216 [Abstract] [Full Text] [Related]
2. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ]. Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S. Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309 [Abstract] [Full Text] [Related]
3. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome]. Duman VL, Shkerina LI, Shilov EM. Klin Med (Mosk); 2005 Aug; 83(10):48-50. PubMed ID: 16320847 [Abstract] [Full Text] [Related]
4. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome]. Duman VL. Ter Arkh; 2002 Aug; 74(6):39-41. PubMed ID: 12136481 [Abstract] [Full Text] [Related]
8. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A. Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410 [Abstract] [Full Text] [Related]
9. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy. Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, Takechi S, Fujishima M. Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476 [Abstract] [Full Text] [Related]
10. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome]. Krasnova TN, Tareeva IE, Shilov EM, Mukhin NA, Miroshnichenko NG. Ter Arkh; 1997 Jan; 69(6):21-3. PubMed ID: 9297266 [Abstract] [Full Text] [Related]
11. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group. Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502 [Abstract] [Full Text] [Related]
12. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study. Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB. Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651 [Abstract] [Full Text] [Related]
13. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis. Opastirakul S, Chartapisak W. J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070 [Abstract] [Full Text] [Related]
14. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M. Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303 [Abstract] [Full Text] [Related]
15. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D. Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719 [Abstract] [Full Text] [Related]
16. Prognostic factors of diffuse proliferative lupus nephritis. Lim CS, Chin HJ, Jung YC, Kim YS, Ahn C, Han JS, Kim S, Lee JS. Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308 [Abstract] [Full Text] [Related]
17. Effective treatment administration of cyclophosphamide in membranous nephropathy. Dede F, Ayili D, Sahiner S. J Nephrol; 2008 Sep; 21(4):560-5. PubMed ID: 18651546 [Abstract] [Full Text] [Related]